Research Topics
Species | P E McBrideSummaryAffiliation: University of Wisconsin Country: USA Publications
| Collaborators
|
Detail Information
Publications
Primary care practice adherence to National Cholesterol Education Program guidelines for patients with coronary heart diseaseP McBride
HEART Preventive Cardiology Program, University of Wisconsin Medical School, Madison 53715 1849, USA
Arch Intern Med 158:1238-44. 1998..National guidelines recommending goals for screening and treatment were published in 1993 and widely disseminated. This study examines cholesterol screening and management by primary care physicians after the guidelines were released...- Triglycerides and risk for coronary artery diseasePatrick McBride
Preventive Cardiology Program, University of Wisconsin School of Medicine and Public Health, 2150 HSLC, 750 Highland Avenue, Madison, WI 53705, USA
Curr Atheroscler Rep 10:386-90. 2008..Treatment of elevated TGs in clinical trials has been shown to reduce CVD events, cardiac deaths, and total mortality... - Assessment and management of cardiovascular risk in menPatrick E McBride
University of Wisconsin School of Medicine and Public Health, 750 Highland Avenue, Madison, WI 53705, USA
Prim Care 33:75-91, viii-ix. 2006 - Putting the Diabetes Prevention Program into practice: a program for weight loss and cardiovascular risk reduction for patients with metabolic syndrome or type 2 diabetes mellitusP E McBride
University of Wisconsin School of Medicine and Public Health, Department of Medicine, and Medicine and Family Medicine, University of Wisconsin Hospital and Clinics, H6 349 Clinical Sciences Center, 600 Highland Avenue, Madison, WI 53792, USA
J Nutr Health Aging 12:745S-749S. 2008.... - Improving prevention systems in primary care practices: the Health Education and Research Trial (HEART)P McBride
Department of Family Medicine, University of Wisconsin Medical School, Madison, USA
J Fam Pract 49:115-25. 2000..We present the trial methodology, the practices' use of medical record tools, and changes in documentation of cardiovascular risk factor screening and management... - The effects of lipid-lowering and antioxidant vitamin therapies on flow-mediated vasodilation of the brachial artery in older adults with hypercholesterolemiaJ H Stein
University of Wisconsin Medical School, Madison, Wisconsin, USA
J Am Coll Cardiol 38:1806-13. 2001..The goal of this study was to determine the long-term effects of statins and antioxidant vitamins on flow-mediated vasodilation of the brachial artery in older adults with hypercholesterolemia... - Organization development strategies for continuing medical educationA B Knox
Departments of Medicine and Family Medicine, University of Wisconsin Medical School, USA
J Contin Educ Health Prof 21:15-23. 2001.... - Short report: factors that affect specialty choice and career plans of Wisconsin's medical studentsKjersti E Knox
University of Wisconsin School of Medicine and Public Health, 760 WARF Building, 610 Walnut St, Madison, WI 53726, USA
WMJ 107:369-73. 2008..To identify factors that influence specialty choice among Wisconsin medical students and provide insight into approaches to encourage more students to pursue careers in primary care... - Medical student exposure to and attitudes about pharmaceutical companiesCody Soyk
Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison 53705, USA
WMJ 109:142-8. 2010..This study assessed students' attitudes toward and interactions with Pharmas at the University of Wisconsin School of Medicine and Public Health (UWSMPH)... - Smoking status after cardiac events and participation in outpatient cardiac rehabilitationWendy Tzou
University of Wisconsin Medical School, Madison 53792 0001, USA
J Cardiopulm Rehabil 24:94-9. 2004..Smoking correlates and predictors were studied after CVD events in outpatient cardiac rehabilitation (OCR) with the aim of characterizing CVD patients at high risk for continued smoking... - Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunctionJ H Stein
Department of Medicine, University of Wisconsin Medical School, Madison, Wisconsin, USA
Circulation 104:257-62. 2001..Because these metabolic and vascular changes predispose to atherosclerosis, monitoring and treatment of dyslipidemia in patients taking these medications is warranted... - The surveillance of cholesterol management in the cardiac rehabilitation settingRachael Wyman
University of Wisconsin Medical School, J5/230 CSC-2454, 600 Highland Avenue, Madison, WI 53792, USA
J Cardiopulm Rehabil 22:245-50. 2002..CONCLUSIONS: There is a high degree of variation among cardiac rehabilitation programs in terms of surveillance and treatment of dyslipidemias for patients with coronary heart disease... - Hyperhomocysteinemia and atherosclerotic vascular disease: pathophysiology, screening, and treatment. offJ H Stein
Preventive Cardiology Program, Department of Medicine, University of Wisconsin Medical School, Madison 53792, USA
Arch Intern Med 158:1301-6. 1998..Until prospective clinical trial data become available, these conservative recommendations provide a safe, effective, and evidence-based approach to the diagnosis, evaluation, and management of patients with hyperhomocysteinemia... - Perspectives: The NCEP ATP III guidelines-friend or foe? National Cholesterol Education ProgramPatrick E McBride
Department of Medicine Cardiovascular, and the Preventive Cardiology Program, University of Wisconsin Medical School, Madison, WI 53792, USA
Prev Cardiol 5:152-5. 2002 - Medical records as sources of data on cardiovascular disease events in persons with diabetesBarbara E K Klein
Department of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, 53726, USA
J Diabetes Complications 20:224-7. 2006..The aim of this study is to evaluate medical records as a source of data on cardiovascular disease over a 20-year interval... - Wisconsin kids, obesity, and health risk: how's their report card?Patrick E McBride
WMJ 105:15-6. 2006 - Effectiveness of ezetimibe added to ongoing statin therapy in modifying lipid profiles and low-density lipoprotein cholesterol goal attainment in patients of different races and ethnicities: a substudy of the Ezetimibe add-on to statin for effectiveness tThomas A Pearson
Department of Community and Preventive Medicine, University of Rochester School of Medicine and Dentistry, NY 14642, USA
Mayo Clin Proc 81:1177-85. 2006..CONCLUSION: Ezetimibe added to statin therapy is effective and well tolerated for improving the lipid profile and LDL-C goal attainment of patients regardless of race or ethnicity... - Should advanced lipoprotein testing be used in clinical practice?James H Stein
Cardiovascular Medicine Division, Department of Medicine, University of Wisconsin Medical School, 600 Highland Avenue, G7 341 CSC MC 3248, Madison, WI 53792, USA
Nat Clin Pract Cardiovasc Med 3:640-1. 2006 - Smoking cessation, but not smoking reduction, reduces plasma homocysteine levelsJames H Stein
Center for Tobacco Research and Intervention, Department of Medicine, University of Wisconsin Medical School, Madison, USA
Clin Cardiol 25:23-6. 2002..CONCLUSION: A "harm reduction" strategy of reducing cigarette use may not be sufficient for reducing the vascular risk associated with smoking cigarettes... - Implications of cardiac risk and low-density lipoprotein cholesterol distributions in the United States for the diagnosis and treatment of dyslipidemia: data from National Health and Nutrition Examination Survey 1999 to 2002Jon G Keevil
University of Wisconsin School of Medicine and Public Health, Madison, USA
Circulation 115:1363-70. 2007..The present study assesses the distribution of low-density lipoprotein cholesterol (LDL-C) in the United States across the 5 groups of CHD risk as defined in the updated guidelines... - Triglycerides and risk for coronary heart diseasePatrick E McBride
JAMA 298:336-8. 2007 - Rationale for targeted rather than population based screening with C-reactive protein using the National Health and Nutrition Examination Survey (1999 to 2002)Brian N Guttormsen
Division of Cardiovascular Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA
Am J Cardiol 100:1130-3. 2007..Patients with 1 risk factor and LDL cholesterol levels of 130 to 159 mg/dl and those with moderately high risk and LDL cholesterol levels of 100 to 129 mg/dl represent high-yield subgroups for routine CRP screening... - Effects of simvastatin on cerebrospinal fluid biomarkers and cognition in middle-aged adults at risk for Alzheimer's diseaseCynthia M Carlsson
Department of Medicine, Section of Geriatrics and Gerontology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53705, USA
J Alzheimers Dis 13:187-97. 2008..It is unclear if statins modify Abeta metabolism or improve cognition in asymptomatic middle-aged adults at increased risk for AD... 
National improvements in low-density lipoprotein cholesterol management of individuals at high coronary risk: National Health and Nutrition Examination Survey, 1999 to 2002Michael W Cullen
Department of Internal Medicine, Mayo School of Graduate Medical Education, Rochester, MN
Am Heart J 156:284-91. 2008..The ATP III guidelines intensified LDL-C targets and defined additional high-risk conditions. These recommendations are expected to have a noticeable impact on US cholesterol levels...- Inaccuracy of lipid measurements with the portable Cholestech L.D.X analyzer in patients with hypercholesterolemiaJames H Stein
University of Wisconsin Medical School, Madison, WI 53792, USA
Clin Chem 48:284-90. 2002..CONCLUSIONS: Lipid values obtained from portable lipid analyzers may be useful for screening, but they should not be used to make clinical decisions regarding the diagnosis and management of dyslipidemia in individual patients... - Postprandial lipoprotein changes in patients taking antiretroviral therapy for HIV infectionJames H Stein
University of Wisconsin Medical School, 600 Highland Ave, G7 341 CSC MC 3248 Madison, WI 53792, USA
Arterioscler Thromb Vasc Biol 25:399-405. 2005..The purpose of this study was to determine whether postprandial lipemia contributes to the dyslipidemia observed in HIV-positive patients taking antiretroviral therapy... - Office systems for heart disease preventionGail Underbakke
Preventive Cardiology Program, University of Wisconsin Hospital and Clinics, Madison, WI 53792, USA
Prim Care 32:883-900. 2005..Once established, the prevention system can improve patient care and satisfaction of practice staff and physicians, but requires on-going assessment, modification, and commitment... - Functional capacity and cardiovascular assessment: submaximal exercise testing and hidden candidates for pharmacologic stressMartha Gulati
Bluhm Cardiovascular Institute, Northwestern University, Chicago, Illinois, USA
Am J Cardiol 96:11J-19J. 2005..The identification of such patients before they fail a maximal exercise test attempt is beneficial to both the patient and the imaging laboratory... - Health-related quality of life and long-term therapy with pravastatin and tocopherol (vitamin E) in older adultsCynthia M Carlsson
University of Wisconsin Medical School, Madison, Wisconsin 53792, USA
Drugs Aging 19:793-805. 2002.... - Rhabdomyolysis from the combination of a statin and gemfibrozil: an uncommon but serious adverse reactionAmy Haavisto Kind
Massachusetts General Hospital, USA
WMJ 101:53-6. 2002..Therefore, patients should be advised to watch for generalized muscle pain or weakness, and if it occurs, stop medications and report symptoms immediately... - Cardiovascular disease preventionJon G Keevil
Department of Medicine, Section of Cardiovascular Medicine, University of Wisconsin Medical School, 3248 600 Highland Avenue H6 349, Madison, WI 53792, USA
Prim Care 29:667-96. 2002..Finally, we discuss some of the barriers that exist on both a global and local level to effective treatment of CHD risk factors... - The association of homocysteine and coronary artery diseaseGregory M Gauthier
Department of Medicine, University of Wisconsin Hospital and Clinics, Madison, Wisconsin 53792, USA
Clin Cardiol 26:563-8. 2003..This article reviews the biochemistry of homocysteine metabolism, pathogeneisis, and etiology of hyperhomocysteinemia, along with its association with coronary artery disease, screening, and treatment... - Nonresponse bias: does it affect measurement of clinician behavior?Leif I Solberg
HealthPartners Research Foundation, PO Box 1524, Minneapolis, MN 55440 1424, USA
Med Care 40:347-52. 2002..Previous studies of nonresponders have not assessed the effects of nonresponse on the accuracy of clinician behavior measurements. Knowledge of these effects is critical to both research and quality improvement... - Lower extremity peripheral arterial disease in hospitalized patients with coronary artery diseaseRobert S Dieter
University of Wisconsin Medical School, Madison, WI, USA
Vasc Med 8:233-6. 2003..Identification of patients with PAD by measuring the ankle-brachial index is easily done... - Vascular age: integrating carotid intima-media thickness measurements with global coronary risk assessmentJames H Stein
University of Wisconsin Atherosclerosis Imaging Research Program, Section of Cardiovascular Medicine, University of Wisconsin Medical School, Madison, Wisconsin 53792, USA
Clin Cardiol 27:388-92. 2004..Determining VA using CIMT values may help individualize the age component of population-based CHD risk estimates. This strategy should be tested in a large trial with hard clinical endpoints... - Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathyBarbara E K Klein
Department of Ophthalmology and Visual Sciences, University of Wisconsin Medical School, Madison 53726, USA
Arch Intern Med 164:1917-24. 2004..Retinal vascular characteristics were associated with these end points, but this association was confounded by nephropathy... - Electrocardiographic abnormalities in individuals with long-duration type 1 diabetesBarbara E K Klein
Department of Ophthalmology and Visual Sciences, University of Wisconsin, School of Medicine, Madison, Wisconsin 53726, USA
Diabetes Care 28:145-7. 2005 - A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trialThomas A Pearson
Department of Community and Preventive Medicine, University of Rochester School of Medicine and Dentistry, 601 Elmwood Ave, Box 644, Rochester, NY 14642, USA
Mayo Clin Proc 80:587-95. 2005..The addition of ezetimibe to statin therapy should be considered for patients not achieving their NCEP ATP III LDL-C goals while receiving statin therapy alone... - Classic intermittent claudication is an uncommon manifestation of lower extremity peripheral arterial disease in hospitalized patients with coronary artery diseaseRobert S Dieter
Cardiovascular Medicine, University of Wisconsin, Madison, WI 53792, USA
Angiology 55:625-8. 2004..Classic claudication is an uncommon manifestation of PAD in hospitalized patients with CAD... - Does detection of carotid plaque affect physician behavior or motivate patients?Rachael A Wyman
Division of Cardiovascular Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA
Am Heart J 154:1072-7. 2007..We evaluated the impact of ultrasound screening to identify carotid artery plaques on physician treatment plans and patient motivation... - The significance of lower extremity peripheral arterial diseaseRobert S Dieter
Section of Cardiovascular Medicine, University of Wisconsin, Madison 53792, USA
Clin Cardiol 25:3-10. 2002..Noninvasive and invasive tests help diagnosis and localize disease. Expanded therapies to improve outcomes include lifestyle changes, medical treatment, interventional cardiovascular procedures, or surgical intervention... - Teaching nutrition skills to primary care practitionersCharles B Eaton
Department of Family Medicine, Center for Primary Care and Prevention, Brown Medical School, Memorial Hospital of Rhode Island, Pawtucket, RI 02860, USA
J Nutr 133:563S-6S. 2003.... - Ultrasound-detected carotid plaque as a predictor of cardiovascular eventsRachael A Wyman
Cardiovascular Medicine Division, University of Wisconsin Medical School, Madison, Wisconsin, USA
Vasc Med 11:123-30. 2006..Ultrasound detection of carotid plaque is a straightforward, inexpensive, and safe tool that has the potential to be used in an office setting to help clarify a patient's CV risk... - Closing the cholesterol treatment gap: cardiac rehabilitation can make a differenceJames H Stein
J Cardiopulm Rehabil 26:363-5. 2006